Notice of Capital Increase to Promote Business Expansion

Proteobridge Corporation has completed a third-party allotment of shares with Nippon Soda Co., Ltd.（Head Office：Chiyoda-ku, Tokyo ; Representative Director and President：Eiji Aga）as the subscriber.

With this funding, we will accelerate the enhancement of quality for our Research Assay A-Cube® Series and HuPEX® comprehensive protein array Contract Analysis Service, as well as the development of new products.

In addition, through a joint research agreement with Nippon Soda Co., Ltd., we have begun applying our protein array technology to the animal health field, further driving new value creation and business growth.

Nippon Soda Co., Ltd.　https://www.nippon-soda.co.jp/e/